Eli Lilly Considers Sale of China Assets to Raise Cash

(Bloomberg) -- Eli Lilly & Co. is considering the sale of a portfolio of off-patent drugs in China as the pharmaceutical firm seeks to raise cash amid a push into higher-growth products, people fam...
BQ Install

Bloomberg Quint

Add BloombergQuint App to Home screen.